NK cell therapy (Belarusian Research Center for Pediatric Oncology, Hematology and Immunology)

N/A

Report date: 2022/08/30 20:00:42

Base Information

Drug NameNK cell therapy (Belarusian Research Center for Pediatric Oncology, Hematology and Immunology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelarus
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBelarusian Research Center For Pediatric Oncology, Hematology And Immunology
China Registration ClassN/A

Develop Information

Active CompaniesBelarusian Research Center For Pediatric Oncology, Hematology And Immunology
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A